Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albee Messing

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
ASN Neuro|February 26, 2013
GFAP expression as an indicator of disease severity in mouse models of Alexander diseasePaige L Jany, Tracy L Hagemann, Albee Messing
Human Molecular Genetics|June 12, 2010
Drug screening to identify suppressors of GFAP expressionWoosung Cho, Michael Brenner, Noel Peters, et al.
Glia|February 2, 2008
GFAP promoter elements required for region-specific and astrocyte-specific expressionYoungjin Lee, Albee Messing, Mu Su, et al.
Journal of Proteome Research|January 1, 2013
Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometryRobert Cunningham, Paige Jany, Albee Messing, et al.
Plos One|July 13, 2017
Characterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAPNi-Hsuan Lin, Albee Messing, Ming-Der Perng
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|August 15, 2002
GFAP mutations in Alexander diseaseRong Li, Albee Messing, James E Goldman, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 1, 2010
Strategies for treatment in Alexander diseaseAlbee Messing, Christine M LaPash Daniels, Tracy L Hagemann
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 5, 2016
An In Vivo Pharmacological Screen Identifies Cholinergic Signaling as a Therapeutic Target in Glial-Based Nervous System DiseaseLiqun Wang, Tracy L Hagemann, Albee Messing, et al.
Experimental Cell Research|May 15, 2007
GFAP and its role in Alexander diseaseRoy A Quinlan, Michael Brenner, James E Goldman, et al.
BMC Research Notes|December 25, 2012
The effect of glial fibrillary acidic protein expression on neurite outgrowth from retinal explants in a permissive environmentKimberly A Toops, Tracy L Hagemann, Albee Messing, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
ASN Neuro|February 26, 2013
GFAP expression as an indicator of disease severity in mouse models of Alexander diseasePaige L Jany, Tracy L Hagemann, Albee Messing
Human Molecular Genetics|June 12, 2010
Drug screening to identify suppressors of GFAP expressionWoosung Cho, Michael Brenner, Noel Peters, et al.
Glia|February 2, 2008
GFAP promoter elements required for region-specific and astrocyte-specific expressionYoungjin Lee, Albee Messing, Mu Su, et al.
Journal of Proteome Research|January 1, 2013
Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometryRobert Cunningham, Paige Jany, Albee Messing, et al.
Plos One|July 13, 2017
Characterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAPNi-Hsuan Lin, Albee Messing, Ming-Der Perng
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|August 15, 2002
GFAP mutations in Alexander diseaseRong Li, Albee Messing, James E Goldman, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 1, 2010
Strategies for treatment in Alexander diseaseAlbee Messing, Christine M LaPash Daniels, Tracy L Hagemann
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 5, 2016
An In Vivo Pharmacological Screen Identifies Cholinergic Signaling as a Therapeutic Target in Glial-Based Nervous System DiseaseLiqun Wang, Tracy L Hagemann, Albee Messing, et al.
Experimental Cell Research|May 15, 2007
GFAP and its role in Alexander diseaseRoy A Quinlan, Michael Brenner, James E Goldman, et al.
BMC Research Notes|December 25, 2012
The effect of glial fibrillary acidic protein expression on neurite outgrowth from retinal explants in a permissive environmentKimberly A Toops, Tracy L Hagemann, Albee Messing, et al.
Pageof 11